Literature DB >> 31576292

Reactive astrocytes foster brain metastases via STAT3 signaling.

Braden C McFarland1, Etty N Benveniste1.   

Abstract

Entities:  

Year:  2019        PMID： 31576292      PMCID： PMC6685879          DOI： 10.21037/atm.2019.04.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.

Authors:  Lee A D Cooper; David A Gutman; Candace Chisolm; Christina Appin; Jun Kong; Yuan Rong; Tahsin Kurc; Erwin G Van Meir; Joel H Saltz; Carlos S Moreno; Daniel J Brat
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

Review 2.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

3.  Stroke target identification guided by astrocyte transcriptome analysis.

Authors:  Cordula Rakers; Melvin Schleif; Nelli Blank; Hana Matušková; Thomas Ulas; Kristian Händler; Santiago Valle Torres; Toni Schumacher; Khalid Tai; Joachim L Schultze; Walker S Jackson; Gabor C Petzold
Journal:  Glia       Date:  2018-12-26       Impact factor: 7.452

Review 4.  Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy.

Authors:  Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Cancer Treat Rev       Date:  2015-04-27       Impact factor: 12.111

5.  The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.

Authors:  Krishna P L Bhat; Katrina L Salazar; Veerakumar Balasubramaniyan; Khalida Wani; Lindsey Heathcock; Faith Hollingsworth; Johanna D James; Joy Gumin; Kristin L Diefes; Se Hoon Kim; Alice Turski; Yasaman Azodi; Yuhui Yang; Tiffany Doucette; Howard Colman; Erik P Sulman; Frederick F Lang; Ganesh Rao; Sjef Copray; Brian D Vaillant; Kenneth D Aldape
Journal:  Genes Dev       Date:  2011-12-15       Impact factor: 11.361

6.  Silibinin is a direct inhibitor of STAT3.

Authors:  Sara Verdura; Elisabet Cuyàs; Laura Llorach-Parés; Almudena Pérez-Sánchez; Vicente Micol; Alfons Nonell-Canals; Jorge Joven; Manuel Valiente; Melchor Sánchez-Martínez; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Food Chem Toxicol       Date:  2018-04-14       Impact factor: 6.023

7.  The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases.

Authors:  Lucile Ben Haim; Kelly Ceyzériat; Maria Angeles Carrillo-de Sauvage; Fabien Aubry; Gwennaëlle Auregan; Martine Guillermier; Marta Ruiz; Fanny Petit; Diane Houitte; Emilie Faivre; Matthias Vandesquille; Romina Aron-Badin; Marc Dhenain; Nicole Déglon; Philippe Hantraye; Emmanuel Brouillet; Gilles Bonvento; Carole Escartin
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

Review 8.  Brain metastasis: Unique challenges and open opportunities.

Authors:  Frank J Lowery; Dihua Yu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-06       Impact factor: 10.680

Review 9.  Reactive Astrocytes in Brain Metastasis.

Authors:  David Wasilewski; Neibla Priego; Coral Fustero-Torre; Manuel Valiente
Journal:  Front Oncol       Date:  2017-12-11       Impact factor: 6.244

10.  The transcriptional network for mesenchymal transformation of brain tumours.

Authors:  Maria Stella Carro; Wei Keat Lim; Mariano Javier Alvarez; Robert J Bollo; Xudong Zhao; Evan Y Snyder; Erik P Sulman; Sandrine L Anne; Fiona Doetsch; Howard Colman; Anna Lasorella; Ken Aldape; Andrea Califano; Antonio Iavarone
Journal:  Nature       Date:  2009-12-23       Impact factor: 49.962
View more
  6 in total

Review 1.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

2.  JAK/STAT signaling pathway-mediated microRNA-181b promoted blood-brain barrier impairment by targeting sphingosine-1-phosphate receptor 1 in septic rats.

Authors:  Sheng-Long Chen; Geng-Xin Cai; Hong-Guang Ding; Xin-Qiang Liu; Zhong-Hua Wang; Yuan-Wen Jing; Yong-Li Han; Wen-Qiang Jiang; Miao-Yun Wen
Journal:  Ann Transl Med       Date:  2020-11

Review 3.  Feed-forward loops between metastatic cancer cells and their microenvironment-the stage of escalation.

Authors:  Zora Baumann; Priska Auf der Maur; Mohamed Bentires-Alj
Journal:  EMBO Mol Med       Date:  2022-05-04       Impact factor: 14.260

4.  Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice.

Authors:  Patrizia Garbati; Raffaella Barbieri; Matilde Calderoni; Francesca Baldini; Mario Nizzari; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

5.  Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson's Disease.

Authors:  Manikandan Samidurai; Prashant Tarale; Chelva Janarthanam; Crystal Gomez Estrada; Richard Gordon; Gary Zenitsky; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Cells       Date:  2020-08-04       Impact factor: 6.600

6.  Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3.

Authors:  Qiuhua Meng; Jing Tian; Feizhang Qin; Xuejing Huang; Dan Zhu; Bangde Xiang; Min Dong
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.